These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12365917)
1. Expectations from clinical trials: results of the Early Manifest Glaucoma Trial. Lichter PR Arch Ophthalmol; 2002 Oct; 120(10):1371-2. PubMed ID: 12365917 [No Abstract] [Full Text] [Related]
2. To treat or not to treat? That is the question. Bullimore MA Optom Vis Sci; 2002 Dec; 79(12):741-2. PubMed ID: 12512682 [No Abstract] [Full Text] [Related]
3. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M; Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904 [TBL] [Abstract][Full Text] [Related]
4. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E; Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884 [TBL] [Abstract][Full Text] [Related]
5. Predictors of long-term progression in the early manifest glaucoma trial. Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z; Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686 [TBL] [Abstract][Full Text] [Related]
6. Disc hemorrhages and treatment in the early manifest glaucoma trial. Bengtsson B; Leske MC; Yang Z; Heijl A; Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244 [TBL] [Abstract][Full Text] [Related]
7. Treatment and vision-related quality of life in the early manifest glaucoma trial. Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC; Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074 [TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial. Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B; Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252 [TBL] [Abstract][Full Text] [Related]
9. What is the appropriate treatment for patients with primary open-angle glaucoma: medicine, laser, or primary surgery? Migdal C Ophthalmic Surg; 1995; 26(2):108-9. PubMed ID: 7596534 [No Abstract] [Full Text] [Related]
10. Structural and Functional Progression in the Early Manifest Glaucoma Trial. Öhnell H; Heijl A; Brenner L; Anderson H; Bengtsson B Ophthalmology; 2016 Jun; 123(6):1173-80. PubMed ID: 26949119 [TBL] [Abstract][Full Text] [Related]
11. Clinical and economic impact of new trends in glaucoma treatment. Marchetti A; Magar R; An P; Nichol M MedGenMed; 2001 Jul; 3(4):6. PubMed ID: 11549985 [TBL] [Abstract][Full Text] [Related]
12. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Bengtsson B; Leske MC; Hyman L; Heijl A; Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736 [TBL] [Abstract][Full Text] [Related]
14. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368 [TBL] [Abstract][Full Text] [Related]
15. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial. Heijl A; Peters D; Leske MC; Bengtsson B Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876 [TBL] [Abstract][Full Text] [Related]
16. Rational choice of therapy in primary open angle glaucoma. Jay JL Eye (Lond); 1992; 6 ( Pt 3)():243-7. PubMed ID: 1446755 [No Abstract] [Full Text] [Related]
17. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Boland MV; Ervin AM; Friedman DS; Jampel HD; Hawkins BS; Vollenweider D; Chelladurai Y; Ward D; Suarez-Cuervo C; Robinson KA Ann Intern Med; 2013 Feb; 158(4):271-9. PubMed ID: 23420235 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. Li X; Wang W; Zhang X BMC Ophthalmol; 2015 Aug; 15():107. PubMed ID: 26286384 [TBL] [Abstract][Full Text] [Related]
19. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Katz J; Congdon N; Friedman DS Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384 [TBL] [Abstract][Full Text] [Related]